These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32661626)

  • 1. Effects of medium cut-off dialysis membranes on inflammation and oxidative stress in patients on maintenance hemodialysis.
    Yeter HH; Korucu B; Akcay OF; Derici K; Derici U; Arinsoy T
    Int Urol Nephrol; 2020 Sep; 52(9):1779-1789. PubMed ID: 32661626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.
    Sevinc M; Hasbal NB; Yilmaz V; Basturk T; Ahbap E; Sakaci T; Ozcafer PN; Unsal A
    Blood Purif; 2020; 49(6):733-742. PubMed ID: 32634815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a medium cut-off dialyzer on inflammation and cardiac and vascular function in hemodialysis patients with heart failure.
    Ozarli I; Yeter HH; Sener YZ; Cebrailov C; Yildirim T; Yilmaz R
    Hemodial Int; 2024 Jul; 28(3):326-335. PubMed ID: 38923655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results from EuCliD (European Clinical Dialysis Database): impact of shifting treatment modality.
    Merello Godino JI; Rentero R; Orlandini G; Marcelli D; Ronco C
    Int J Artif Organs; 2002 Nov; 25(11):1049-60. PubMed ID: 12487392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy.
    Danielski M; Ikizler TA; McMonagle E; Kane JC; Pupim L; Morrow J; Himmelfarb J
    Am J Kidney Dis; 2003 Aug; 42(2):286-94. PubMed ID: 12900810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E-Bonded Membranes Do Not Influence Markers of Oxidative Stress in Hemodialysis Patients with Homozygous Glutathione Transferase M1 Gene Deletion.
    Djuric P; Suvakov S; Simic T; Markovic D; Jerotic D; Jankovic A; Bulatovic A; Tosic Dragovic J; Damjanovic T; Marinkovic J; Naumovic R; Dimkovic N
    Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32471186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Hemodialysis with Medium Cut-Off versus High-Flux Membranes on Endothelial Function of Patients with Chronic Kidney Disease.
    Armani RG; Carvalho AB; Vercia Rocha E Silva M; Verardino R; Bortolotto L; Canziani MEF
    Blood Purif; 2024; 53(7):565-573. PubMed ID: 38330931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of hemodialysis membrane permeability on serum paraoxonase-1 activity and oxidative status parameters.
    Horoz M; Kiykim AA; Cimen B; Erdem A
    Artif Organs; 2011 Oct; 35(10):923-9. PubMed ID: 21517907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
    Ikizler TA; Morrow JD; Roberts LJ; Evanson JA; Becker B; Hakim RM; Shyr Y; Himmelfarb J
    Clin Nephrol; 2002 Sep; 58(3):190-7. PubMed ID: 12356187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.
    Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho YJ; Wong MG; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Darssan D; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA
    BMC Nephrol; 2018 Apr; 19(1):89. PubMed ID: 29665795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device Study.
    Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho Y; Wong M; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA
    Blood Purif; 2020; 49(4):468-478. PubMed ID: 31968346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Medium Cut-Off Dialyzers on Malnutrition-Inflammation Scores in Maintenance Hemodialysis Patients.
    Sahutoglu T; Erinc O; Avsar FN
    Blood Purif; 2024; 53(3):219-228. PubMed ID: 38142670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
    Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
    PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial.
    Belmouaz M; Bauwens M; Hauet T; Bossard V; Jamet P; Joly F; Chikhi E; Joffrion S; Gand E; Bridoux F
    Nephrol Dial Transplant; 2020 Feb; 35(2):328-335. PubMed ID: 31578564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H; Dallas L; Nair S; Palmer J; Thaikandy S; Hutchison C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32408589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study.
    Herič T; Vivoda T; Bogataj Š; Pajek J
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33805509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of Losartan on oxidative stress and inflammation in non-diabetic patients undergoing chronic hemodialysis.
    Kayabasi H; Yilmaz Z; Sit D; Kadiroglu AK; Yilmaz E
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):235-42. PubMed ID: 23377814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.